Published in Mol Pharmacol on March 01, 1993
Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J (1998) 1.62
Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides. Br J Pharmacol (2002) 1.03
Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons. J Gen Physiol (1996) 0.95
Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes. Br J Pharmacol (1999) 0.87
Binding and effect of K ATP channel openers in the absence of Mg2+. Br J Pharmacol (2003) 0.85
Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney. J Physiol (1999) 0.81
Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075. Br J Pharmacol (2004) 0.79
Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta. Br J Pharmacol (1995) 0.78
The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2. Br J Pharmacol (2005) 0.77
Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure. Br J Pharmacol (2001) 0.76
KATP channel openers of the benzopyran type reach their binding site via the cytosol. Br J Pharmacol (2006) 0.76
Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet (1994) 1.59
Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler (1986) 1.45
Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol (1987) 1.41
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Submucosal plexus and electrolyte transport across rat colonic mucosa. J Physiol (1985) 1.30
The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol (1990) 1.26
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. J Med Chem (2000) 1.21
The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.15
Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.11
Survivors of self-inflicted firearm injury. A liaison psychiatry perspective. Med J Aust (1994) 1.08
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib. Leukemia (2011) 1.06
The order and orientation of mouse lambda-genes explain lambda-rearrangement patterns. J Immunol (1988) 1.02
Su-6668. SUGEN. Curr Opin Investig Drugs (2001) 0.94
The contribution of Rb-permeable potassium channels to the relaxant and membrane hyperpolarizing actions of cromakalim, RP49356 and diazoxide in bovine tracheal smooth muscle. Br J Pharmacol (1991) 0.94
The hydragogue and laxative effect of the sulfuric acid ester and the free diphenol of 4,4'-dihydroxydiphenyl-(pyridyl-2)-methane. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.90
Comparison of nilotinib and imatinib inhibition of FMS receptor signaling, macrophage production and osteoclastogenesis. Leukemia (2007) 0.90
Cromakalim inhibits contractions of the rat isolated mesenteric bed induced by noradrenaline but not caffeine in Ca(2+)-free medium: evidence for interference with receptor-mediated Ca2+ mobilization. Eur J Pharmacol (1991) 0.84
[Method for induction of iron deficiency in rats]. Arzneimittelforschung (1969) 0.83
Properties and organ distribution of ATP citrate (pro-3S)-lyase. Biochim Biophys Acta (1980) 0.82
In vitro studies on the mode of action of pinacidil. Drugs (1988) 0.81
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol (2001) 0.80
Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers. J Med Chem (1993) 0.80
Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent. J Med Chem (1983) 0.80
Identification of small peptide analogues having agonist and antagonist activity at the platelet thrombin receptor. Biochem Pharmacol (1988) 0.79
The potassium channel openers: a new class of vasorelaxants. Blood Vessels (1990) 0.79
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors. J Med Chem (1987) 0.78
Immunoassay of ergotamine and dihydroergotamine using a common 3H-labelled ligand as tracer for specific antibody and means to overcome experienced pitfalls. Int J Nucl Med Biol (1984) 0.78
Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Transplantation (2001) 0.77
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol (2000) 0.77
Thrombin receptor antagonists. Structure-activity relationships for the platelet thrombin receptor and effects on prostacyclin synthesis by human umbilical vein endothelial cells. Biochem Pharmacol (1990) 0.76
Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol (2001) 0.75
Identification of a specific binding site for K+ channel openers in rat aorta. Jpn J Pharmacol (1992) 0.75
[Closer team work and new methods better than unit nurses]. Sygeplejersken (1985) 0.75
[On the problem of regulating the iron resorption by gastroferrin, an iron binding protein of the gastric juice]. Klin Wochenschr (1968) 0.75
[Senile dementia--in a home community with support]. Sygeplejersken (1992) 0.75
Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivo. Thromb Haemost (1988) 0.75
Development of a permanently controllable rotating biopsy device, Part I: theoretical considerations and in-vitro results for five different prototypes. Rofo (2009) 0.75
Activators of protein kinase A induce a glibenclamide-sensitive 86Rb+ efflux in rat isolated aorta. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.75
The individual enantiomers of cis-cromakalim possess K+ channel opening activity. Eur J Pharmacol (1993) 0.75
The mode of action of pinacidil and its analogs P1060 and P1368: results of studies in rat blood vessels. J Cardiovasc Pharmacol (1988) 0.75
Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.75
[Synthesis of racemic pumiliotoxin C]. Naturwissenschaften (1975) 0.75
5-[6-1 -(Cyclohexyl-1 H-tetrazol-5-YL)hexyl]-1,8-naphthyridin-2-(1H)-one, SC-44368, a Potent Anti-aggregatory Agent which Selectively Inhibits Platelet Cyclic AMP Phosphodiesterase. Platelets (1992) 0.75
Magnetic excitations of CsMn(SO4)2.12d(2)O, measured by inelastic neutron scattering. J Am Chem Soc (2001) 0.75
Dibenzoquinazoline diones as antihypertensive cyclic guanosine monophosphate phosphodiesterase inhibitors. Biochem Pharmacol (1987) 0.75
[Determination of cardiac troponin I on Stratus analyzer: prospective evaluation in unstable angina]. Ann Biol Clin (Paris) (1996) 0.75
Relation between serum cardiac troponin I values and severity of clinical, electrocardiographic and quantitative angiographic features in unstable angina. Indian Heart J (1999) 0.75
[Labeling of active principles by stable isotopes]. Therapie (1987) 0.75
Prostaglandins, thromboxanes, leukotrienes, and related arachidonic acid metabolites. Nat Prod Rep (1984) 0.75
[Metabolic dependency of binding and penetration of iron studies on isolated gut segments]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage. Protein Expr Purif (1998) 0.75
Influences of age and obesity on ATP citrate (pro-3S)-lyase activities in the rat. Hoppe Seylers Z Physiol Chem (1980) 0.75